相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma
Iris Helfrich et al.
CANCERS (2019)
The Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment
Eline Biscop et al.
CANCERS (2019)
Plasma Medicine: A Field of Applied Redox Biology
Thomas von Woedtke et al.
IN VIVO (2019)
Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression
Yasuhiko Okubo et al.
EXPERIMENTAL CELL RESEARCH (2018)
Plasmas for Treating Cancer: Opportunities for Adaptive and Self-Adaptive Approaches
Michael Keidar et al.
TRENDS IN BIOTECHNOLOGY (2018)
Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
Ping Yin et al.
CANCER SCIENCE (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies
Andreea Calinescu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who receivedplatinum-taxane first-line therapy
S. Pontikakis et al.
PHARMACOGENOMICS JOURNAL (2017)
Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell
Seungyeon Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Reactive oxygen species and cancer paradox: To promote or to suppress?
Sehamuddin Galadari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy
Feihu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells
Effrosini G. Panayotopoulou et al.
ONCOTARGET (2017)
Use of cold atmospheric plasma in the treatment of cancer
Parker Babington et al.
BIOINTERPHASES (2015)
Use of cold atmospheric plasma in the treatment of cancer
Parker Babington et al.
BIOINTERPHASES (2015)
Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes
Laurence Froidevaux-Klipfel et al.
ONCOTARGET (2015)
Diacylglycerol lipase a knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice
David R. Powell et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
Camilo Guzman et al.
PLOS ONE (2014)
Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Samuel A. Jensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CEACAM1 Promotes Melanoma Cell Growth through Sox-2
Rona Ortenberg et al.
NEOPLASIA (2014)
Restoration of Sensitivity in Chemo - Resistant Glioma Cells by Cold Atmospheric Plasma
Julia Koeritzer et al.
PLOS ONE (2013)
Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo
Fumi Utsumi et al.
PLOS ONE (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
Taxane resistance in breast cancer: A closed HER2 circuit?
Joep P. J. de Hoon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
S. Murray et al.
CANCER TREATMENT REVIEWS (2012)
Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
Karen To et al.
CANCER RESEARCH (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Biomarkers and multiple drug resistance in breast cancer
L. O'Driscoll et al.
CURRENT CANCER DRUG TARGETS (2006)
Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer
S Modi et al.
CANCER INVESTIGATION (2005)
Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
SH Giordano et al.
CANCER (2004)
Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer
K Nemoto et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2003)
分享论文
